Literature DB >> 8369406

Eutectic mixed monolayers in equilibrium with phospholipid-bilayers and triolein-liquid phase.

T Handa1, H Saito, K Miyajima.   

Abstract

Triolein (TO) and phospholipids (egg yolk phosphatidylcholine, egg yolk phosphatidylethanolamine, and bovine brain phosphatidylserine) had low mutual solubilities and separated into the TO-liquid phase and phospholipid-bilayers. Spreading pressures of the TO-phospholipid mixture (i.e., surface pressures of the mixed monolayer in equilibrium with the phase-separating lipid mixture) at the air/saline interface were independent of the lipid composition. On the other hand, collapse pressures of the mixed monolayer of TO and phospholipid (i.e., surface pressures of the mixed monolayer in equilibrium with the TO-liquid phase) at the interface changed with the monolayer composition and were lower than the spreading pressure. The experimental data indicated the spreading and collapse pressures as offering a phase diagram for the presence of equilibrium between the mixed monolayer, the phospholipid-bilayers and the TO-liquid phase. The diagram showed that TO and the phospholipids were miscible in the mixed monolayer, forming an eutectic mixed monolayer. When the mixed monolayer initially had the eutectic composition, no collapse of the monolayer was detected until the surface pressure reached the value of the spreading pressure. No specific complex between TO and the phospholipid is required to explain the stability and collapse of the mixed monolayers. The bulk immiscibility of the lipids elucidated by the spreading pressure-measurements, immediately leads to the phase behaviors observed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8369406      PMCID: PMC1262510          DOI: 10.1016/S0006-3495(93)81547-9

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  9 in total

1.  Phospholipid monolayers at the triolein-saline interface: production of microemulsion particles and conversion of monolayers to bilayers.

Authors:  T Handa; H Saito; K Miyajima
Journal:  Biochemistry       Date:  1990-03-20       Impact factor: 3.162

2.  Interactions of triglycerides with phospholipids: incorporation into the bilayer structure and formation of emulsions.

Authors:  J A Hamilton
Journal:  Biochemistry       Date:  1989-03-21       Impact factor: 3.162

3.  Interaction of differently oriented lipids in monolayer: mixed monolayers of 16-(9-anthroyloxy)palmitic acid with phosphatidylcholine and cholesterol.

Authors:  M Nakagaki; K Tomita; T Handa
Journal:  Biochemistry       Date:  1985-08-13       Impact factor: 3.162

4.  Triolein-cholesteryl oleate-cholesterol-lecithin emulsions: structural models of triglyceride-rich lipoproteins.

Authors:  K W Miller; D M Small
Journal:  Biochemistry       Date:  1983-01-18       Impact factor: 3.162

5.  Regulation of cholesteryl oleate and triolein miscibility in monolayers and bilayers.

Authors:  J M Smaby; H L Brockman
Journal:  J Biol Chem       Date:  1987-06-15       Impact factor: 5.157

6.  Surface-to-core and interparticle equilibrium distributions of triglyceride-rich lipoprotein lipids.

Authors:  K W Miller; D M Small
Journal:  J Biol Chem       Date:  1983-11-25       Impact factor: 5.157

7.  Medium-chain versus long-chain triacylglycerol emulsion hydrolysis by lipoprotein lipase and hepatic lipase: implications for the mechanisms of lipase action.

Authors:  R J Deckelbaum; J A Hamilton; A Moser; G Bengtsson-Olivecrona; E Butbul; Y A Carpentier; A Gutman; T Olivecrona
Journal:  Biochemistry       Date:  1990-02-06       Impact factor: 3.162

8.  Modification by diacylglycerol of the structure and interaction of various phospholipid bilayer membranes.

Authors:  S Das; R P Rand
Journal:  Biochemistry       Date:  1986-05-20       Impact factor: 3.162

9.  Miscibility, chain packing, and hydration of 1-palmitoyl-2-oleoyl phosphatidylcholine and other lipids in surface phases.

Authors:  J M Smaby; H L Brockman
Journal:  Biophys J       Date:  1985-11       Impact factor: 4.033

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.